PFIZERPEN (penicillin g potassium) by Pfizer is clinical pharmacology aqueous penicillin g is rapidly absorbed following both intramuscular and subcutaneous injection. Approved for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. First approved in 1968.
Drug data last refreshed 18h ago
CLINICAL PHARMACOLOGY Aqueous penicillin G is rapidly absorbed following both intramuscular and subcutaneous injection. Initial blood levels following parenteral administration are high but transient. Penicillins bind to serum proteins, mainly albumin. Therapeutic levels of the penicillins are…
Worked on PFIZERPEN at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo